Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111K Hold
2,126
0.02% 351
2026
Q1
$117K Hold
2,126
0.03% 316
2025
Q4
$104K Hold
2,126
0.03% 332
2025
Q3
$91.8K Hold
2,126
0.02% 363
2025
Q2
$81.6K Buy
+2,126
New +$81.2K 0.02% 378
2024
Q4
$77.5K Hold
2,291
0.02% 361
2024
Q3
$93.7K Sell
2,291
-82
-3% -$3.35K 0.03% 339
2024
Q2
$91.4K Sell
2,373
-12,638
-84% -$532K 0.03% 318
2024
Q1
$644K Buy
+15,011
New +$619K 0.22% 117

Other funds holding GSK

Hilltop National Bank's GSK Position: Q2 2026 in Review

Hilltop National Bank held its GSK (GSK) position steady in Q2 2026 at 2,126 shares worth $111K. The position accounts for 0.02% of the portfolio, ranked #351.

Hilltop National Bank first reported a position in GSK in Q1 2024 and has held it in 9 quarters since. The position peaked at $644K in Q1 2024. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Hilltop National Bank held 2,126 shares of GSK worth $111K as of Q2 2026.
  • Hilltop National Bank left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.02% of Hilltop National Bank's portfolio in Q2 2026, its #351 holding.
  • Hilltop National Bank first reported a position in GSK in Q1 2024 and has held it in 9 quarters since.
  • Hilltop National Bank's GSK position peaked at $644K in Q1 2024.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.